New Insight Into the Pathogenesis of Cerebral Small-Vessel Diseases

Affiliations

¹ From the Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany (K.M., M.S.); INSERM U1038/BIG, CEA, Grenoble, France (G.C.); and Institute of Genetics and Biophysics, "Adriano Buzzati-Traverso", IGB-CNR, Naples, Italy (M.V.U.).
² From the Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany (K.M., M.S.); INSERM U1038/BIG, CEA, Grenoble, France (G.C.); and Institute of Genetics and Biophysics, "Adriano Buzzati-Traverso", IGB-CNR, Naples, Italy (M.V.U.). markus.schwaninger@pharma.uni-luebeck.de.

Review

Kristin Müller et al. Stroke. 2017 Feb.

. 2017 Feb;48(2):520-527.

doi: 10.1161/STROKEAHA.116.012888. Epub 2017 Jan 12.

¹ From the Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany (K.M., M.S.); INSERM U1038/BIG, CEA, Grenoble, France (G.C.); and Institute of Genetics and Biophysics, "Adriano Buzzati-Traverso", IGB-CNR, Naples, Italy (M.V.U.).
² From the Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany (K.M., M.S.); INSERM U1038/BIG, CEA, Grenoble, France (G.C.); and Institute of Genetics and Biophysics, "Adriano Buzzati-Traverso", IGB-CNR, Naples, Italy (M.V.U.). markus.schwaninger@pharma.uni-luebeck.de.

No abstract available

Keywords: Alzheimer disease; CADASIL; blood-brain barrier; incontinentia pigmenti; transforming growth factor beta.

Publication types